Browse by Uncontrolled Keywords

Export as [feed] Atom [feed] RSS
Group by: Year | Authors/Creators | Item Type | Full Text
Number of items: 5.

Bibliographic data only

Coombes, RC; Gibson, L; Hall, E; Emson, M; Bliss, J; (2003) Aromatase inhibitors as adjuvant therapies in patients with breast cancer. The Journal of steroid biochemistry and molecular biology, 86 (3-5). pp. 309-11. ISSN 0960-0760 DOI: Full text not available from this repository.

George, WD; Houghton, J; Austoker, J; Bishop, H; Cuzick, J; Fentiman, IS; Forbes, JF; Foster, E; Ellis, I; Leinster, S; +25 more... Spittle, M; Joslin, C; Stewart, H; Baum, M; Campbell, R; Elston, C; Stroner, P; Taylor, I; Teasdale, C; Cooke, T; McPherson, K; Priestman, T; Sloane, J; Williams, N; Riley, D; Moritz, S; Wells, U; Bellenger, K; Coles, E; Chan, J; MacDonald, C; Douglas, A; Wilson, A; Hornery, S; Lindsay, D; (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet, 362 (9378). pp. 95-102. ISSN 0140-6736 Full text not available from this repository.

Zachariah, R; Spielmann, M.-, PL; Chinji, C; Gomani, P; Arendt, V; Hargreaves, NJ; Salaniponi, FM; Harries, AD; (2003) Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS (London, England), 17 (7). pp. 1053-1061. ISSN 0269-9370 DOI: Full text not available from this repository.


Barrett, A; Roques, T; Small, M; Smith, RD; (2006) How much will Herceptin really cost? BMJ, 333 (7578). pp. 1118-20. ISSN 1468-5833 DOI:

Coombes, RC; Hall, E; Gibson, LJ; Paridaens, R; Jassem, J; Delozier, T; Jones, SE; Alvarez, I; Bertelli, G; Ortmann, O; +17 more... Coates, AS; Bajetta, E; Dodwell, D; Coleman, RE; Fallowfield, LJ; Mickiewicz, E; Andersen, J; Lønning, PE; Cocconi, G; Stewart, A; Stuart, N; Snowdon, CF; Carpentieri, M; Massimini, G; Bliss, JM; van de Velde, C; Intergroup Exemestane Study; (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. The New England journal of medicine, 350 (11). pp. 1081-92. ISSN 0028-4793 DOI:

This list was generated on Thu Jul 25 02:11:18 2019 BST.